Quantcast

Latest Peptides Stories

2010-11-10 13:44:00

PALO ALTO, Calif., Nov. 10, 2010 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) announced today it will report data from the Phase 2 randomized multicenter study of Telintra® (ezatiostat HCl) tablets in the treatment of patients with Myelodysplastic Syndrome at the 52nd Annual Meeting of the American Society of Hematology in Orlando, FL. Details of the presentation are as follows: Abstract #2910 -Myelodysplastic Syndromes: Poster II; Sunday, December 5,...

2010-11-05 00:00:39

AnyGen manufactures the highest purity peptide available in the market (98% vs. 95% for most competitors) and specializes in difficult and long sequences for peptide synthesis. ISO Certified, it is the first Korean peptide manufacturer to obtain GMP (Good Manufacturing Practice) status for its production facility. New York, NY (Vocus) November 4, 2010 Korean Biotechnology leader AnyGen is launching its high-level custom-made and catalogue peptides for the first time in the U.S. AnyGen...

2010-11-03 09:32:00

BASKING RIDGE, N.J., Nov. 3, 2010 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be presenting at IMPACT 2010 held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Ms. McDonald's presentation will be given at 11:13 a.m. EST on Wednesday, November 10 in the Life Science Room #106AB and will...

2010-11-03 09:17:00

BASKING RIDGE, N.J., Nov. 3, 2010 /PRNewswire/ -- Regado Biosciences, Inc., a private biopharmaceutical company leading the development of antithrombotic aptamers with matched active control agents, announced today that it has received funding from the United States government under the Qualifying Therapeutic Discovery Project (QTDP) grants program to advance the development of the company's three programs, REG1, REG2 and REG3. The total grant amount allocated to Regado was more than...

2010-11-02 18:30:00

BASKING RIDGE, N.J., Nov. 2, 2010 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Steven L. Zelenkofske, D.O., F.A.C.C., Senior Vice President and Chief Medical Officer, presented an abstract at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions on November 2, 2010 in Vancouver, BC, Canada. The abstract is titled "Sustained Inhibition of...

2010-11-02 06:30:00

CRANBURY, N.J., Nov. 2, 2010 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN), announced today that it has received $978,000 in grants under the Patient Protection and Affordable Care Act of 2010 (PPACA), with $847,000 available immediately and $131,000 available no later than 30 days after Palatin's fiscal year ending June 30, 2011. The grants are related to four of Palatin's projects - melanocortin agonists for sexual dysfunction; melanocortin agonists for obesity and...

cd9f292bc56f0abdbd2ad8e308dd53151
2010-10-30 12:45:46

Researchers led by Vanderbilt's Roger Cone, Ph.D., have discovered a new member of a gene family that has powerful influences on pigmentation and the regulation of body weight.The gene is the third member of the agouti family. Two agouti genes have been identified previously in humans. One helps determine skin and hair color, and the other may play an important role in obesity and diabetes. The new gene, called agrp2, has been found exclusively in bony fish, including zebrafish, trout and...

2010-10-26 09:17:00

BASKING RIDGE, N.J., Oct. 26 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J. Mazzo, PhD, President and CEO, will be presenting at the Oppenheimer 21st Annual Healthcare Conference. Dr. Mazzo's presentation will be given at the Waldorf-Astoria Hotel in New York City on Tuesday, November 2, 2010 at 10:45 a.m. EDT in the Louis XVI Room. The presentation will include an overview...

2010-09-30 09:12:28

(Ivanhoe Newswire) -- Researchers have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage using aptamer-based proteomics array technology. This novel technology would enable better clinical diagnosis for two of the most aggressive and deadly forms of cancer -- pancreatic and mesothelioma.  Moreover, it would provide insight into new therapeutic targets. "Currently these cancers are detected at an advanced stage, where the possibility of cure is...

2010-09-28 20:51:00

Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer "” pancreatic and mesothelioma. This technology would enable better clinical diagnosis at an earlier stage and may provide insight into new therapeutic targets, said Rachel Ostroff, Ph.D., clinical research director of Somalogic Inc. "Currently...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related